Cargando…
Selective inhibition of phosphodiesterases 4, 5 and 9 induces HSP20 phosphorylation and attenuates amyloid beta 1–42‐mediated cytotoxicity
Phosphodiesterase (PDE) inhibitors are currently under evaluation as agents that may facilitate the improvement of cognitive impairment associated with Alzheimer's disease. Our aim was to determine whether inhibitors of PDEs 4, 5 and 9 could alleviate the cytotoxic effects of amyloid beta 1–42...
Autores principales: | Cameron, Ryan T., Whiteley, Ellanor, Day, Jon P., Parachikova, Anna I., Baillie, George S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221464/ https://www.ncbi.nlm.nih.gov/pubmed/28097089 http://dx.doi.org/10.1002/2211-5463.12156 |
Ejemplares similares
-
Nasal mucosal inhalation of amyloid-beta peptide 3–10 defective adenovirus attenuates cytotoxicity induced by beta-amyloid (1–42)
por: Jiang, Tongzi, et al.
Publicado: (2014) -
The phosphorylation of Hsp20 enhances its association with amyloid-β to increase protection against neuronal cell death
por: Cameron, Ryan T., et al.
Publicado: (2014) -
The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
por: Ring, Julia, et al.
Publicado: (2022) -
RAB40C regulates RACK1 stability via the ubiquitin–proteasome system
por: Day, Jon P, et al.
Publicado: (2018) -
secHsp70 as a tool to approach amyloid-β42 and other extracellular amyloids
por: De Mena, Lorena, et al.
Publicado: (2017)